Hugel, a biopharmaceutical company, announced Thursday that it has entered into a joint marketing agreement with Hanmi Pharmaceutical to target the domestic urology market.

Under the contract, the two companies will cooperate in all sales and marketing activities for domestic urology specialists to expand sales of Gugu filler, a new hyaluronic acid filler product for penis enlargement.

Hugel is the first local company that has penis enlargement indications for their HA fillers and plans to supply the product to Hanmi pharmaceutical.

“Based on Hugel's penis enlargement HA filler technology and Hanmi Pharmaceutical's urogynecology market share, we hope that the company can provide customers with convenient and differentiated benefits,” a company official said.

Hugel will further strengthen its business capabilities in the domestic and overseas cosmetics markets and continue to expand its business.